MedPath

Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism

Not Applicable
Conditions
cirrhotic patients who underwent laparoscopic splenectomy
Registration Number
JPRN-UMIN000002289
Lead Sponsor
Department of Surgery and Science, Kyushu University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients who had portal vein thrombosis before the operation. 2. Patients who had post-operative bleeding requiring hemostasis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison of the incidence of portal vein thrombosis between cirrhotic patients with or without AT-III concentrates
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath